Individuals with hormone-sensitive cancers like breast or ovarian cancer should consult an oncologist due to what potential lavender effect?

Potential anti-androgenic effects

Caution is strongly advised for individuals managing hormone-sensitive cancers, such as those involving breast, ovarian, or uterine tissues, where estrogen regulation is critical to the disease progression or treatment plan. This caution is rooted in research suggesting that compounds found in lavender, particularly when concentrated, may function as endocrine disruptors. Specifically, these compounds have been implicated in exhibiting anti-androgenic properties, which means they might interfere with the body’s ability to properly utilize or balance natural hormones like androgens and estrogens. Given that these conditions are directly tied to hormonal levels, the theoretical risk of introducing any substance, even mildly, that exhibits endocrine-disrupting characteristics warrants consultation and likely avoidance unless expressly cleared by the treating oncologist.